| FunRich: An open access standalone functional enrichment and interaction network analysis tool M Pathan, S Keerthikumar, CS Ang, L Gangoda, CYJ Quek, ... Proteomics 15 (15), 2597-2601, 2015 | 1066 | 2015 |
| Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary CancerGenomic Landscape of Colorectal Cancer Cell Lines D Mouradov, C Sloggett, RN Jorissen, CG Love, S Li, AW Burgess, ... Cancer research 74 (12), 3238-3247, 2014 | 390 | 2014 |
| Tolerance of Whole-Genome Doubling Propagates Chromosomal Instability and Accelerates Cancer Genome EvolutionGenome Doubling Accelerates Cancer Evolution SM Dewhurst, N McGranahan, RA Burrell, AJ Rowan, E Grönroos, ... Cancer discovery 4 (2), 175-185, 2014 | 363 | 2014 |
| SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer NI Fleming, RN Jorissen, D Mouradov, M Christie, A Sakthianandeswaren, ... Cancer research 73 (2), 725-735, 2013 | 333 | 2013 |
| Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations D Mouradov, E Domingo, P Gibbs, RN Jorissen, S Li, PY Soo, L Lipton, ... Official journal of the American College of Gastroenterology| ACG 108 (11 …, 2013 | 162 | 2013 |
| A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data C Yau, D Mouradov, RN Jorissen, S Colella, G Mirza, G Steers, A Harris, ... Genome biology 11 (9), 1-15, 2010 | 158 | 2010 |
| Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis M Christie, RN Jorissen, D Mouradov, A Sakthianandeswaren, S Li, F Day, ... Oncogene 32 (39), 4675-4682, 2013 | 138 | 2013 |
| PIK3CA and PTEN Gene and Exon Mutation-Specific Clinicopathologic and Molecular Associations in Colorectal CancerCharacteristics of PIK3CA-or PTEN-Mutated Colorectal Cancer FL Day, RN Jorissen, L Lipton, D Mouradov, A Sakthianandeswaren, ... Clinical cancer research 19 (12), 3285-3296, 2013 | 133 | 2013 |
| Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 2014; 4: 175–185. doi: 10.1158/2159-8290 SM Dewhurst, N McGranahan, RA Burrell, AJ Rowan, E Gronroos, ... CD-13-0285.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 94 | |
| Structural basis for recruitment of tandem hotdog domains in acyl-CoA thioesterase 7 and its role in inflammation JK Forwood, AS Thakur, G Guncar, M Marfori, D Mouradov, W Meng, ... Proceedings of the National Academy of Sciences 104 (25), 10382-10387, 2007 | 81 | 2007 |
| Translational incorporation of L‐3,4‐dihydroxyphenylalanine into proteins K Ozawa, MJ Headlam, D Mouradov, SJ Watt, JL Beck, KJ Rodgers, ... The FEBS journal 272 (12), 3162-3171, 2005 | 74 | 2005 |
| Colorectal cancer cell line proteomes are representative of primary tumors and predict drug sensitivity J Wang, D Mouradov, X Wang, RN Jorissen, MC Chambers, ... Gastroenterology 153 (4), 1082-1095, 2017 | 60 | 2017 |
| Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community … E Domingo, C Camps, PJ Kaisaki, MJ Parsons, D Mouradov, MM Pentony, ... The Lancet Gastroenterology & Hepatology 3 (9), 635-643, 2018 | 57 | 2018 |
| Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes DS Williams, D Mouradov, RN Jorissen, MR Newman, E Amini, ... Gut 68 (3), 465-474, 2019 | 52 | 2019 |
| MACROD2 Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal TumorsMACROD2 Loss Impairs PARP1 Activity and … A Sakthianandeswaren, MJ Parsons, D Mouradov, RN MacKinnon, ... Cancer discovery 8 (8), 988-1005, 2018 | 40 | 2018 |
| Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer RN Jorissen, M Christie, D Mouradov, A Sakthianandeswaren, S Li, ... British journal of cancer 113 (6), 979-988, 2015 | 40 | 2015 |
| Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion N Sengupta, C Yau, A Sakthianandeswaren, D Mouradov, P Gibbs, ... Molecular cancer 12, 1-11, 2013 | 37 | 2013 |
| Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ–Dependent MannerIL33 Promotes a Protective IFNγ Response in Colon Cancer MF Eissmann, C Dijkstra, MA Wouters, D Baloyan, D Mouradov, ... Cancer immunology research 6 (4), 409-421, 2018 | 35 | 2018 |
| Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer N Suraweera, D Mouradov, S Li, RN Jorissen, D Hampson, A Ghosh, ... Oncotarget 7 (24), 36474, 2016 | 32 | 2016 |
| Identification of disulfide-containing chemical cross-links in proteins using MALDI-TOF/TOF-mass spectrometry GJ King, A Jones, B Kobe, T Huber, D Mouradov, DA Hume, IL Ross Analytical chemistry 80 (13), 5036-5043, 2008 | 32 | 2008 |
Oliver SieberLaboratory Head, Walter and Eliza Hall Institute of Medical ResearchПотвърден имейл адрес: wehi.edu.au
